标签归档：mage

MAGE-A3 (195-203)

发表于由

MAGE-A3 (195-203);

MAGE-A3 (195-203) 是一种由黑色素瘤抗原基因 A3 (MAGE-A3) 编码的人类白细胞抗原分子 HLA-A24 抗原决定簇。

MAGE-A3 (195-203)amp;;

MAGE-A3 (195-203) Chemical Structure

CAS No. : 171066-85-6

规格 是否有货
100 mg ; 询价 ;
250 mg ; 询价 ;
500 mg ; 询价 ;

* Please select Quantity before adding items.

生物活性

MAGE-A3 (195-203) is a human leukocyte antigen (HLA) -A24 molecules epitope encoded by melanoma antigen gene (MAGE)[1].

分子量

955.30

Formula

C45H82N10O10S
CAS 号

171066-85-6
Sequence Shortening

IMPKAGLLI
运输条件

Room temperature in continental US; may vary elsewhere.
储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.
参考文献

  • [1]. So T, et al. Lack of tumor recognition by cytolytic T lymphocyte clones recognizing peptide 195-203 encoded by gene MAGE-A3 and presented by HLA-A24 molecules. Cancer Immunol Immunother. 2007 Feb;56(2):259-69.

MAGE-3 (271-279)

发表于由

MAGE-3 (271-279);

MAGE-3 (271-279) 是一个由 MAGE-3 编码的黑色素瘤抗原的 271-279 序列的短肽。MAGE-3 是一种 CTL 定义的 MAGE-3 蛋白，与人类白细胞抗原 (HLA)-A2 分子相关。MAGE-3 在包括恶性黑色素瘤在内的不同人类肿瘤类型中过表达，但在睾丸和胎盘以外的正常组织中没有过表达。

MAGE-3 (271-279)amp;;

MAGE-3 (271-279) Chemical Structure

CAS No. : 160295-81-8

规格 是否有货
100 mg ; 询价 ;
250 mg ; 询价 ;
500 mg ; 询价 ;

* Please select Quantity before adding items.

生物活性

MAGE-3 (271-279) is a 271-279 residue peptide derived from melanoma antigens encoded by MAGE-3. MAGE-3 is a cytolytic T lymphocyte (CTL)-defined MAGE-3 protein associated with the human leukocyte antigen (HLA)-A2 molecule. MAGE-3 is overexpressed in different human tumor types, including malignant melanoma, but not by normal tissues except for testis and placenta[1].

分子量

1058.28

Formula

C53H79N13O10
CAS 号

160295-81-8
Sequence

Phe-Leu-Trp-Gly-Pro-Arg-Ala-Leu-Val
Sequence Shortening

FLWGPRALV
运输条件

Room temperature in continental US; may vary elsewhere.
储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.
参考文献

  • [1]. J Herman, et al. A peptide encoded by the human MAGE3 gene and presented by HLA-B44 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE3. Immunogenetics. 1996;43(6):377-83.